https://www.selleckchem.com/products/avelumab.html
32 (1.22-1.43), 0.001). At four hours, 19·6% (12·9-27·9) of the 'Yes' group had attained a target RASS of -1, 0 or 1, compared to 13·6% (8·0-21· of those in the 'No' group. This proportion increased to 55·6% (46·1-64·9) at 24h compared with 44·9% (35·6-54·4) in the 'No' group. Ceasing sedative infusions as soon as possible, is safe and feasible, in both medical and surgical patients, and can be implemented into 'real life' with no additional staffing. Ceasing sedative infusions as soon as possible, is safe and feasible, in both m
Curtir
Comentario
Compartilhar
